Combining biomarkers for prognostic modelling of Parkinson's disease.

Nirosen Vijiaratnam Michael A Lawton Amanda J Heslegrave Tong Guo Manuela M X Tan Edwin Jabbari Raquel RealJohn WoodsideKatherine GrossetViorica Chelban Dilan Athauda Christine Girges Roger A BarkerJohn HardyNicholas WoodHenry Houlden Nigel M Williams Yoav Ben-Shlomo Henrik Zetterberg Donald G Grosset Thomas Foltynie Huw R Morrisnull null

Published in: Journal of neurology, neurosurgery, and psychiatry (2022)

Clinical trials of disease-modifying therapies might usefully stratify patients using clinical, genetic and NfL status at the time of recruitment.

Keyphrases